e-learning
resources
European Respiratory Review
2008
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
CPAP increases bronchial reactivity in OSAS patients
Korczynski P., Gorska K., Bielicki P., Byskiniewicz K., Zielinski J., Chazan R.
Source:
Eur Respir Rev 2008; 17: 101-102
Journal Issue:
June 2008 - 17 (108)
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Korczynski P., Gorska K., Bielicki P., Byskiniewicz K., Zielinski J., Chazan R.. CPAP increases bronchial reactivity in OSAS patients. Eur Respir Rev 2008; 17: 101-102
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
The effect of CPAP in asthma patients with SAHS
Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes
Year: 2021
Bronchial reactivity in patients with obstructive sleep apnea syndrome treated with continuous positive airway pressure
Source: Eur Respir J 2005; 26: Suppl. 49, 569s
Year: 2005
The reversibility of hypoxemia in OSA patients is related to CPAP therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 112s
Year: 2005
Effects of CPAP treatment in UARS patients comparing to OSAS patients
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007
Impact of CPAP on asthmatic patients with obstructive sleep apnoea
Source: Eur Respir J 2007; 29: 307-311
Year: 2007
CPAP treatment induces changes in lung diffusion in OSA patients
Source: Eur Respir J 2005; 26: Suppl. 49, 111s
Year: 2005
Automatic bi-level positive airway pressure therapy in non compliant CPAP patients with obstructive sleep apnoea
Source: Annual Congress 2007 - Sleep apnoea and adaptive servo–ventilation
Year: 2007
Adherence to positive airway pressure in non-sleepy patients with obstructive sleep apnoea
Source: Eur Respir J 2013; 42: 863-866
Year: 2013
CPAP setting prediction in OSAS patients
Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea
Year: 2011
A study of insulin resistance in moderate to severe obstructive sleep apnea in non diabetics and its response to nasal CPAP treatment
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011
Evaluation of continuous positive airway pressure compliance in a group of obstructive sleep apnea patients
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012
Exhaled breath markers in patients with obstructive sleep apnea (OSA): baseline assessment and the impact of treatment with nasal continuous positive airway pressure
Source: Eur Respir J 2005; 26: Suppl. 49, 355s
Year: 2005
Comparison of auto-adjusting and fixed positive airway pressure therapy in patients with mild to moderate obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 95s
Year: 2003
Nasal continuous positive airway pressure treatment improves elevated soluble CD40 ligand in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 331s
Year: 2004
Continuous positive airway pressure adherence declines with age in elderly obstructive sleep apnoea patients
Source: ERJ Open Res, 5 (1) 00178-2018; 10.1183/23120541.00178-2018
Year: 2019
Nasal resistance and CPAP compliance in a large series of obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2006; 28: Suppl. 50, 408s
Year: 2006
Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP
Source: Eur Respir J 2007; 30: 496-500
Year: 2007
Nasal inflammation and compliance with nasal CPAP therapy in obstructive sleep apnoea (OSA)
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept